Pall introduces proprietary bioreactor control system

The mPath bioreactor control system is the first to be developed and delivered by a technology supplier specifically for their product line, allowing full access to bioreactor capabilities that current commercial solutions cannot provide.

“Throughout the development of the mPath bioreactor control system, our team was focused on simplifying single-use lab-scale bioprocesses with a functional, integrated user experience,” explained Loe Cameron, Director of Analytics and Controls at Pall. “The architecture makes plug-and-play connectivity a reality, while providing access to features of Pall bioreactors that other commercial control options do not allow. In addition, the mPath bioreactor control system has been designed to support characterization and optimization, and is compliant with cGMP regulations.”

An expandable control and data management system includes both bioreactor control towers and an advanced supervisory control and data acquisition (SCADA) software package. The mPath control tower is cleanroom-ready after being IP54 designed and tested, and comes with features such as six mass flow controllers (MFCs) as standard. There are three variable speed pumps for feeds, titrants and media fills, and three biocontainer hangers with integrated load cells to organize and weigh titrants, feeds and media with a minimal footprint. All of this comes at no additional cost to buyers, and there are no limits on the number of systems or users that can run the control software.

“At Pall, we remain driven to advance the biopharmaceutical industry by delivering innovative total solutions to end users,” said Martin Smith, Chief Technology Officer at Pall. “The launch of the mPath bioreactor control system represents the first in our next generation of unifying technologies for a seamless, fully controlled, and value-based user experience.”